Literature DB >> 23672656

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

T J de Villiers1, A Pines, N Panay, M Gambacciani, D F Archer, R J Baber, S R Davis, A A Gompel, V W Henderson, R Langer, R A Lobo, G Plu-Bureau, D W Sturdee.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23672656     DOI： 10.3109/13697137.2013.795683

Source DB:  PubMed          Journal:  Climacteric        ISSN： 1369-7137            Impact factor:   3.005


× No keyword cloud information.
  40 in total

1.  Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo.

Authors:  Susan R Davis
Journal:  Nat Rev Endocrinol       Date:  2013-10-29       Impact factor: 43.330

2.  Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO.

Authors:  L Vignozzi; N Malavolta; P Villa; G Mangili; S Migliaccio; S Lello
Journal:  J Endocrinol Invest       Date:  2018-11-19       Impact factor: 4.256

Review 3.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

4.  Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis.

Authors:  Tamara Goldberg; Brooke Fidler
Journal:  P T       Date:  2015-03

Review 5.  Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.

Authors:  P Lehert; P Villaseca; E Hogervorst; P M Maki; V W Henderson
Journal:  Climacteric       Date:  2015-09-11       Impact factor: 3.005

6.  Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.

Authors:  V W Henderson
Journal:  Climacteric       Date:  2014-08-17       Impact factor: 3.005

Review 7.  Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.

Authors:  Jasmin Grigg; Roisin Worsley; Caroline Thew; Caroline Gurvich; Natalie Thomas; Jayashri Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  2017-09-09       Impact factor: 4.530

8.  Applying concepts of life course theory and life course epidemiology to the study of bladder health and lower urinary tract symptoms among girls and women.

Authors:  Sonya S Brady; Amanda Berry; Deepa R Camenga; Colleen M Fitzgerald; Sheila Gahagan; Cecilia T Hardacker; Bernard L Harlow; Jeni Hebert-Beirne; D Yvette LaCoursiere; Jessica B Lewis; Lisa K Low; Jerry L Lowder; Alayne D Markland; Gerald McGwin; Diane K Newman; Mary H Palmer; David A Shoham; Ariana L Smith; Ann Stapleton; Beverly R Williams; Siobhan Sutcliffe
Journal:  Neurourol Urodyn       Date:  2020-03-02       Impact factor: 2.696

9.  Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists.

Authors:  Angela H E M Maas; Giuseppe Rosano; Renata Cifkova; Alaide Chieffo; Dorenda van Dijken; Haitham Hamoda; Vijay Kunadian; Ellen Laan; Irene Lambrinoudaki; Kate Maclaran; Nick Panay; John C Stevenson; Mick van Trotsenburg; Peter Collins
Journal:  Eur Heart J       Date:  2021-03-07       Impact factor: 29.983

10.  The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.

Authors:  Jennifer L Gordon; David R Rubinow; Lana Watkins; Alan L Hinderliter; Melissa C Caughey; Susan S Girdler
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 6.134
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.